carcinosarcoma
Showing 26 - 50 of 111
Endometrial Adenocarcinoma, Endometrial Carcinosarcoma Trial in United States (Nivolumab, BMS- 986205)
Active, not recruiting
- Endometrial Adenocarcinoma
- Endometrial Carcinosarcoma
- Nivolumab
- BMS- 986205
-
Basking Ridge, New Jersey
- +6 more
Nov 29, 2021
Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors Trial in
Not yet recruiting
- Stage I Testicular Seminoma
- +13 more
- Oncological Follow-up
-
Amiens, France
- +2 more
Aug 12, 2022
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)
Active, not recruiting
- BRCA1 Gene Mutation
- +9 more
- Laboratory Biomarker Analysis
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 16, 2022
Breast Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia (Metformin
Active, not recruiting
- Breast Carcinoma
- +4 more
- Metformin Hydrochloride
- Doxycycline
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 28, 2022
Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in
Recruiting
- Fallopian Tube Carcinosarcoma
- +28 more
- Pegylated Liposomal Doxorubicin Hydrochloride
- Peposertib
-
Aurora, Colorado
- +7 more
Sep 2, 2022
Endometrial Cancer, Uterine Carcinosarcoma Trial in New York, Bethlehem, Milwaukee (Rucaparib, Bevacizumab, Atezolizumab)
Active, not recruiting
- Endometrial Cancer
- Uterine Carcinosarcoma
- Rucaparib
- +2 more
-
New York, New York
- +2 more
Apr 4, 2022
Carcinosarcoma of Ovary, Carcinosarcoma of Uterus, Carcinosarcoma of Vagina Trial in Birmingham (Cabozantinib, Ipilimumab,
Withdrawn
- Carcinosarcoma of Ovary
- +2 more
- Cabozantinib
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Feb 18, 2021
Uterine Cancer, Endometrial Carcinoma, Carcinosarcoma Trial in United States (Nivolumab)
Active, not recruiting
- Uterine Cancer
- +6 more
-
Basking Ridge, New Jersey
- +7 more
Apr 4, 2022
MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)
Active, not recruiting
- MSI-H Colorectal Cancer
- +30 more
-
Badalona, Barcelona, Spain
- +9 more
Oct 24, 2022
Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in
Active, not recruiting
- Endometrial Adenosquamous Carcinoma
- +9 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +18 more
Oct 15, 2022
Stage IA Uterine Sarcoma, Stage IB Uterine Sarcoma, Stage IC Uterine Sarcoma Trial in Bronx (drug, radiation, other)
Terminated
- Stage IA Uterine Sarcoma
- +10 more
- paclitaxel
- +5 more
-
Bronx, New YorkAlbert Einstein College of Medicine
Apr 21, 2021
Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States
Active, not recruiting
- Ovarian Brenner Tumor
- +11 more
- Adavosertib
- +5 more
-
Duarte, California
- +15 more
Aug 11, 2022
Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)
Recruiting
- Bone Sarcoma
- +15 more
- Aldesleukin
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2022
Carcinosarcoma, Endometrial Tumors Trial in United Kingdom (Paclitaxel, Cediranib, Olaparib)
Active, not recruiting
- Carcinosarcoma
- Endometrial Neoplasms
- Paclitaxel
- +2 more
-
Northwood, Middlesex, United Kingdom
- +14 more
Feb 10, 2022
Endometrioid Adenocarcinoma, Serous Carcinoma, Clear Cell Carcinoma Trial in London (Image-guided adjuvant pelvic radiotherapy)
Recruiting
- Endometrioid Adenocarcinoma
- +4 more
- Image-guided adjuvant pelvic radiotherapy
-
London, Ontario, CanadaLondon Regional Cancer Program
Sep 2, 2020
The Immune Landscape of Epithelial Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- Collection of tumor samples, blood and vaginal and rectal swabs
-
Bellinzona, SwitzerlandOncology Institute of Southern Switzerland
Aug 2, 2023
Leiomyosarcoma or Carcinosarcoma Trial in Germany (Pazopanib plus Gemcitabine, Pazopanib)
Recruiting
- Leiomyosarcoma or Carcinosarcoma
- Pazopanib plus Gemcitabine
- Pazopanib
-
Bad Saarow, Germany
- +8 more
Nov 27, 2020
Fallopian Tube Carcinoma, Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma Trial in United States
Completed
- Fallopian Tube Carcinoma
- +37 more
- Bevacizumab
- +5 more
-
Birmingham, Alabama
- +22 more
Oct 19, 2021
Leiomyosarcoma, Endometrial Stromal Tumors, Carcinosarcomas Uterine Trial in Graz (Vorinostat Oral Capsule)
Terminated
- Leiomyosarcoma
- +2 more
- Vorinostat Oral Capsule
-
Graz, AustriaMedical University of Graz, Clinic of Obstetrics and Gynecology
Jul 27, 2020
Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus Trial in Philadelphia (Radiotherapy)
Completed
- Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus
- Radiotherapy
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Nov 25, 2019
Endometrial Carcinoma, Stage 0 Fallopian Tube Cancer AJCC v7, Stage I Fallopian Tube Cancer AJCC v6 and v7 Trial in New
Withdrawn
- Endometrial Carcinoma
- +55 more
- Internet-Based Intervention
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 16, 2021
Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma Trial in Philadelphia (Laboratory Biomarker Analysis, Thalidomide)
Completed
- Recurrent Uterine Corpus Sarcoma
- Uterine Carcinosarcoma
- Laboratory Biomarker Analysis
- Thalidomide
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019